Polycystic ovarian syndrome: need for life course approach
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20203018Keywords:
Life cycle approach, Polycystic ovarian disease, Polycystic ovarian syndromeAbstract
Polycystic ovarian syndrome (PCOS) is one of the leading but treatable causes of infertility among women. PCOS is a heterogeneous condition therefore it involves multiple disciplines and there is a wide research and clinical agenda. The prevalence of PCOS in India among 15-24 year old adolescents and young girls was found by Rotterdam criteria to be 22.5% and by Androgen Excess Society criteria to be 10.7%. Earlier it was considered only as a reproductive disorder but now it includes metabolic and psychological features as well. Under diagnosis of PCOS remains to be problematic. This is a complex syndrome and has an influence throughout the lifespan and requires multidisciplinary treatment approach as well as self-management. The life course approach or life course theory or the life course perspective was explored in 1960’s. In this approach individual's lives are analyzed within structural, social, and cultural contexts.
References
Goldenberg N, Glueck C. Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation. Minerva Ginecol. 2008;60(1):63-75.
Boomsma C, Fauser B, Macklon N. Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med. 2008;26(1):72-84.
March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25:544-51.
Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27:3067-73.
Joshi B, Mukherjee S, Patil A, Purandare A, Chauhan S, Vaidya R. A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India. Indian J Endocrinol Metab. 2014;18(3):317-24.
Adam B, Roy H, Stephen F. Defining polycystic ovary syndrome. Br Med J. 2009;338(7692):426.
David E. Polycystic ovary syndrome. N Engl J Med. 2005;352(12):1223-36.
Stephen F. Polycystic ovary syndrome. N Engl J Med. 1995;333:853-61.
Teede HJ, Misso ML, Deeks AA. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust. 2011;195:65-112.
Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:41.
Gainie MA, Kalra S. Polycystic ovary syndrome: a metabolic malady, the mother of all lifestyle disorders in women Can Indian health budget tackle it in future? Indian J Endocrinol Metab. 2011;15:239-41.
Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol. 2011;24:223-7
Nair MK, Pappachan P, Balakrishnan S, Leena ML, George B, Russell PS. Menstrual irregularity and poly cystic ovarian syndrome among adolescent girls: A two year follow-up study. Indian J Pediatr. 2012;79(1):69-73.
Vaidya RA. Polycystic ovarian syndrome, a public health issue: Indian perspective oration delivered at the national institute for research in reproductive health ICMR- on the occasion of NIRRH 24 the Foundation Day.
Azziz R, Marin C, Hoq L, Badamgarav E, Song P. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab. 2005;90:4650-8.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19-25.
Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Morreale HF, Futterweit W, et al. Androgen excess society. position statement: criteria for defining pcos as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab. 2006;91:4237-45.
Vaidya RA, Joshi B. Adolescent obesity and PCOS: A dual emergence during childhood and/or pubertal transition. Manuscript accepted for book on Obesity in children and adolescents, An IJCP. In press.
Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv. 2004;59:141-54.
Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C, et al. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod. 1995;10:2107-11.
Kiddy DS, Sharp PS, White DM, Scanlon MF, Mason HD, Bray CS, et al. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin Endocrinol. 1990;32:213-20.
Glen H, Johnson MK, Crosnoe R. The emergence and development of life course theory. In: Mortimer JT, Shanahan MJ. Handbook of the Life Course. Springer. 2003:3-19.
White JM. Klein DM. Family Theories. Sage. 3rd edition. ISBN.122.
Jump up^ A Life Course Approach to Chronic Disease Epidemiology (Diana Kuh and Yoav Ben-Shlomo ed.). Oxford: Oxford University Press. 1997. ISBN 0-19-262782-1.
Elder GH. Human lives in changing societies: life course and developmental insights. In: Cairns RB, Elder GH, Costello EJ, editors. Developmental Science. Cambridge, UK. Cambridge University Press. 1996.
Elder GH, Shanahan MJ. The life course and human development. In: Damon W, Lerner RM, editors. Handbook of child psychology. 6th edition. Hoboken, USA. John Wiley and Sons. 2006.
Pasquali R, Gambineri A. Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age. Ann NY Acad Sci. 2006;1092(1):158-74.
Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8(1):41-50.
Niet JE, Koning CM, Pastoor H. Psychological well-being and sexarche in women with polycystic ovary syndrome. Hum Reprod. 2010;25(6):1497-503.
McCook JG. The influence of obesity, androgenism and fertility status on the psychosocial health and wellbeing of women with polycystic ovary syndrome. Fertil Steril. 2001;76(3):29.
Månsson M, Holte J, Wilhelmsen LK, Dahlgren E, Johansson A, Landén M. Women with polycystic ovary syndrome are often depressed or anxious – case control study. Psychoneuro Endocrinol. 2008;33(8):1132-8.
Farrell K, Antoni MH. Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertil Steril. 2010;94(5):1565-74.
Hahn S, Benson S, Elsenbruch S. Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality. Hum Reprod. 2006;21(7):1925-34.
Glocker HM, Davidson K, Kochman L, Guzick D, Hoeger K. Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin. Fertil Steril. 2010;93(3):1016-9.
Azziz R. Long-term morbidity of PCOS. In: Azziz R, editor. The polycystic ovary syndrome: current concepts on pathogenesis and clinical care. Boston, MA. Springer. 2007;27.
Carmina E, Guastella E, Rizzo M. When periods stop: long-term con¬sequences of PCOS. In: Farid NR, Kandarakis DE, editors. Diagnosis and management of polycystic ovary syndrome. Boston, MA. Springer. 2009.
Dowdy D. Emotional needs of teens with polycystic ovary syndrome. J Pediatr Nurs. 2012;27(1):55-64.
Trent ME, Rich M, Austin SB, Gordon CM. Fertility concerns and sexual behavior in adolescent girls with polycystic ovary syndrome: implications for quality of life. J Pediatr Adolesc Gynecol. 2003;16(1):33-7.
Rofey D, Szigethy E, Noll R, Dahl R, Iobst E, Arslanian S. Cognitive behavioral therapy for physical and emotional disturbances in adolescents with polycystic ovary syndrome: a pilot study. J Pediatr Psychol. 2009;34(2):156-63.
Percy C. Does a generic lay-led self-management programme help women with polycystic ovary syndrome? A qualitative evaluation. Abstract presented at the Society for Endocrinology BES. 2008.
